Otsuka And Click Therapeutics Announce The U.S. Food And Drug Administration (FDA) Clearance Of Rejoyn, The First Prescription Digital Therapeutic Authorized For The Adjunctive Treatment Of Major Depressive Disorder (MDD) Symptoms

Media coverage

• Title	Otsuka And Click Therapeutics Announce The U.S. Food And Drug Administration (FDA) Clearance Of Rejoyn, The First Prescription Digital Therapeutic Authorized For The Adjunctive Treatment Of Major Depressive Disorder (MDD) Symptoms
  Media name/outlet	Drug Discovery Online
  Country/Territory	United States
  Date	10/04/24
  URL	https://www.drugdiscoveryonline.com/doc/otsuka-and-click-therapeutics-announce-the-u-s-fda-clearance-of-rejoyn-the-first-prescription-of-major-depressi-0001
  Persons	Brian Iacoviello